about
Notes for developing a molecular test for the full characterization of circulating tumor cellsSuppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1Effects of glucose-regulated protein94 (Grp94) on Ig secretion from human blood mononuclear cellsRetaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients.Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.Human miRNome profiling in colorectal cancer and liver metastasis development.Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer.Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death.Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions.Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells.Possible applications of circulating tumor cells in patients with non small cell lung cancer.VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells.Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralization.M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis.The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells.Inhibition of immunoglobulin secretion from peripheral blood mononuclear cells by glucose-regulated protein94 (Grp94) in allergic subjects.Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow.Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared.Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC).DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation.Detection and Prognostic Relevance of Circulating and Disseminated Tumour Cell in Dogs with Metastatic Mammary Carcinoma: A Pilot StudyCTCs 2020: Great Expectations or Unreasonable DreamsDynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerEPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerDysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
P50
Q26778913-AD7E4069-1078-47EF-B184-CBE6B5CF7347Q33696192-E48E6B23-7A90-4806-AF6E-2D7CC6197919Q34797231-7295AE69-3F17-451F-9A19-11808626630DQ34971918-23D0DBE5-DA5A-463A-9DE3-4BB451F0F223Q34976152-D0911D5C-641D-4051-A201-3A259C1072E2Q35814028-BDA2B491-A94F-4F8C-91E5-24EB713A1150Q36387861-FE4B873B-E8D7-4D18-852E-9F5BDF89C59EQ36891578-0F6C34E9-7BFB-4078-8A21-87C7AF66DFBCQ37465975-E200923D-025E-47B4-84ED-B47DD5EB3578Q37687316-F6C214B9-11D1-43CE-ACE4-992D55757D41Q38875351-E95A2097-6E9F-439F-AE55-125CD4AEFF2FQ38941727-FF8A4A67-3390-49E0-ADD0-3BB735FE86D0Q39547351-49136F96-8609-4CEF-A396-883A9BBAA9A3Q39639547-2B8A7956-BC9E-45B7-BC8D-6DD4E167D4A7Q39960772-D5A246BA-2ACC-4935-84DA-63D5EC099F87Q40565403-B95EBD05-474D-4E3A-87FD-2753C1F92860Q42500995-96EF4182-5512-47ED-9486-3C00230E61E9Q44574317-CF39AA54-7E4B-4935-BD49-B701E4983A4FQ47134673-DA74ADF5-7B61-41A2-A721-64B4C57A89A1Q53778077-36DB7C19-803F-4E86-8D53-B9AD4E5D4942Q54186977-EF4B8D16-D54C-4576-A4AA-DBA5DF71056EQ54724096-6AE70BAD-0624-4D94-91AD-E20B9FB0D454Q64245103-05A47015-F94E-4D3E-B786-C423ED50A2F7Q92960474-6532286F-455D-4099-A407-91A74B255A54Q93012639-4AC194F3-4B7C-4F3B-A5C6-C1050466F9BFQ93123598-8D5EB21E-6138-4954-A2E3-548D22B1BEBBQ93185034-65139A17-1BFE-4EDE-B69C-675D3551FEAF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elisabetta Rossi
@ast
Elisabetta Rossi
@en
Elisabetta Rossi
@es
Elisabetta Rossi
@nl
Elisabetta Rossi
@sl
type
label
Elisabetta Rossi
@ast
Elisabetta Rossi
@en
Elisabetta Rossi
@es
Elisabetta Rossi
@nl
Elisabetta Rossi
@sl
prefLabel
Elisabetta Rossi
@ast
Elisabetta Rossi
@en
Elisabetta Rossi
@es
Elisabetta Rossi
@nl
Elisabetta Rossi
@sl
P106
P1153
56470259000
P21
P31
P496
0000-0002-5242-9568